LIVE
Real-Time
NEWS MONITOR
--:--:--
⬤ LOW 31 Oct 2026, 10:00 UTC

Gym bros love BPC-157, the peptide in the 'Wolverine shot.' Now it could go mainstream.

Trump's HHS has eased restrictions on BPC-157, a buzzy recovery peptide in the "Wolverine shot." But human evidence is scant.
TECH MARKETS
\
↗ Read Full Story ← Back to Monitors
Share: Twitter/X LinkedIn
Latest in Markets
⬤ LOW
Muthoot Finance Q2 Results: Profit Rises 27% To Rs 2,977 Crore, Revises Gold Loan Growth Guidance For FY27
NDTV - Business · 6 min ago
⬤ CRITICAL
Palak Tiwari And Ibrahim Ali Khan Break Up On Amicable Terms, Cancel Joint Shoots
NDTV - Business · 7 min ago
⬤ CRITICAL
SEBI Issues Warning Letter To PC Jeweller MD, Company Secretary | Here's Why
NDTV - Business · 8 min ago
⬤ LOW
Mega Bullet Train Plan: Delhi-Varanasi Journey To Be Cut To 3.5 Hours - Check Lucknow, Agra, Patna Travel Time
NDTV - Business · 8 min ago
⬤ LOW
SpaceX Is Up 37% From Its August Low. A $5,000 Investment Could Be Worth This Much by 2028.
Motley Fool · 9 min ago
Terms of Service